May 5, 2008
The following new/updated information was posted to the NGC Web site the week of May 5, 2008.
Centers for Disease Control and Prevention
(1) Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). (2) Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 24--59 months who are not completely vaccinated. This is an addendum to a previously published guideline summary.
Cincinnati Children's Hospital Medical Center
Evidence based clinical practice guideline hypertrophic pyloric stenosis. This updates a previously published guideline summary.
Evidence-based care guideline for cytomegalovirus prophylaxis following solid organ transplants. This updates a previously published guideline summary.
Institute for Clinical Systems Improvement
Assessment and management of acute pain. This updates a previously published guideline summary.
National Institute for Health and Clinical Excellence (NICE)
Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma.
Structural neuroimaging in first-episode psychosis.
Singapore Ministry of Health
Diagnosis and management of headache. This updates a previously published guideline summary.
Newly Submitted
To view a list of other guidelines in the NGC work queue, please visit our
Guidelines In Progress page.
Health Awareness Topics - May 2008
Effective Health Care
Two new summary guides are available from AHRQ's Effective Health Care Program:
Guideline Literature
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ; GRADE Working Group.
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008 Apr 26;336(7650):924-6.
Conference News
- AHRQ's 2008 Annual Conference is September 7-10 in Bethesda, MD. Learn about AHRQ's latest research aimed at improving quality, safety, efficiency, and effectiveness of care from leading experts involved in AHRQ-sponsored research and implementation projects.
- Sunday, September 7, 2008: NGC/NQMC Clearinghouse Day (by invitation only) -- Bringing together developer organizations participating in NGC and NQMC for the purposes of (1) exchanging information related to guideline and measure development, dissemination, implementation, and maintenance, (2) discussing ways to forge closer relationships between guidelines and measures to facilitate improved patient care, and (3) providing insight to AHRQ and its technical contractor for NGC and NQMC, ECRI Institute, on how to improve these resources.
- Monday, September 8, 2008: GRADE Workshop for Guideline Developers -- The GRADE Working Group has developed a sensible and systematic approach to grading quality of evidence and strength of clinical recommendations. In this workshop, members of the GRADE Working Group will share their approach with guideline developers, offer guided assistance in applying the approach to case examples, and highlight "best practices" and helpful resources. By attending this workshop, guideline developers will gain an understanding of the GRADE methodology and be better prepared to develop evidence-based clinical practice guidelines that have greater consistency and transparency.
- The 5th annual Guidelines International Network (G-I-N) conference, will be held October 1-3, 2008. Register online now. The theme of the conference is "Implementation in Practice." Special focus will be given to guideline implementation, collaboration in guideline production, evidence in guidelines, and guidelines and power. For further information and details about registration, please visit the G-I-N Conference Web site.
Healthy People 2010
See NGC's
Frequently Requested Search page for a selection of pre-set searches of NGC for guidelines related to the
Healthy People 2010 focus areas, as well as other public health and patient safety topics.
Recent U.S. Food and Drug Administration (FDA) Advisories
- May 1, 2008: Enbrel (etanercept): Revisions to prescribing information including a BOXED WARNING about infections. The ADVERSE REACTIONS section of the label was updated to include information regarding global clinical studies and the rate of occurrence of tuberculosis in patients treated with Enbrel.
- April 28, 2008: Digitek (digoxin tablets, USP): A Class I nationwide recall of all strengths of Digitek due to the possibility that tablets with double the appropriate thickness may contain twice the approved level of the active ingredient.
NGC's Sister Resources
Find Innovations and
QualityTools classified by disease or clinical category, patient population, stage of care, setting of care, and more in AHRQ's
Health Care Innovations Exchange Web site.
Look for Quality Measures in AHRQ's
National Quality Measures Clearinghouse (NQMC).
Other Resources
To locate a previous issue of "What's New This Week," go to the
What's New Archive.
Questions or suggestions about the "What's New" feature are welcome -- please send e-mail to:
info@guideline.gov.
Submit your guidelines for inclusion in the National Guideline Clearinghouse!
Subscriptions
To sign up for our weekly NGC Update Service or to manage your subscriptions, visit the
Subscription Management page.
